Genzyme Boosts Offer for Anormed, Topping Millennium (Update2) Bloomberg - By Catherine Larkin. Oct. 10 (Bloomberg) - - Genzyme Corp. increased its offer to buy Anormed Inc. to $580 million in cash, topping Millennium Pharmaceuticals Inc.

Americans Are Shelling Out More Money for Halloween Than Ever Before

http://www.fen.com [Family Education Network __title__ Family Education Network]—the leading online publisher of educational expertise, practical guidance and grade specific (K-12) information for teachers, parents, and kids — today announced ...